Our third Open Science event answered the question “Can scientifically substantiated smoke-free products contribute to public health outcomes?” with a resounding YES. People who don’t smoke should never start, and people who currently smoke should quit as quickly as possible. For people who would  otherwise continue to smoke cigarettes: we, as a tobacco company, can really make a positive difference by developing and scientifically assessing new smoke-free products that represent an acceptable alternative to continued smoking.

  PMI's research Cube in Neuchâtel
   dots   

Why cigarettes are bad for health

Many people believe that nicotine or tar are the biggest problems with smoking, but that’s not correct. It’s the thousands of chemicals contained in cigarette smoke, largely formed when tobacco is burned, that are the biggest issue. Among the 6,000 chemicals produced in a burning cigarette, around 100 of these are associated with smoking-related diseases. They’re present in high concentrations in the cigarette smoke and inhaled, and their damage to the body builds up over time, leading to disease. The more smokers who develop smoking-related diseases, the bigger the impact on public health.

Reducing this negative impact on public health requires fewer people to start smoking, and more people to quit smoking altogether. However, according to current trends, approximately 1 billion people will continue to smoke cigarettes in the foreseeable future.

How smoke-free products can make a difference

Two things need to happen for smoke-free products to make a difference. First, the product needs to be developed and scientifically assessed to be sure whether the product is less harmful than cigarettes. Second, men and women who smoke cigarettes should be encouraged to switch to such a product, if they would otherwise continue to smoke cigarettes. A product that presents less risk than cigarettes, with a high level of acceptance and switching among adults who would otherwise continue to smoke, can have a dramatic impact on public health. An impact for the better.

It sounds simple, but there's a lot of work and scientific research involved, as our scientists described in this virtual conference.

Harm reduction equation
    

Open Science: February 17th, 2021

Our latest Open Science webinar focused on Core Concepts on February 17th, 2021. This session, hosted by Dr. Gizelle Baker, VP Global Scientific Engagement,  included three presentations, listed below. During the Q&A sessions, we also welcomed the expertise of Dr. Matthew Hankins, Global Head Real-World Evidence, Epidemiology, and Data Science.

  

Can scientifically substantiated smoke-free products positively contribute to public health?
Presented by Dr. Mikael Franzon, Senior Global Scientific Advisor

 
  

Our leading tobacco heating system: findings to date
Presented by Dr. Andrea Costantini, Head of Regional Scientific Engagement for Latin America & Canada

  
  

Product acceptance and use
Presented by Mr. Steve Roulet, Global Head Behavioral Research Insights

 
dots   

Related articles

Risk reduction for smokers thumbnail

How to achieve risk reduction for smokers

designing smoke free future green thumbnail

Designing a smoke-free future

RELATED ARTICLES BOOKLET MASTER

PMI Science Booklet research overview

RELATED ARTICLES FAQ MASTER

Tobacco Harm Reduction FAQ

RELATED ARTICLES FINDINGS MASTER

Our findings

Patrick Picavet

What is harm reduction?

thumb 3 and multi on blue

Platform 1

Patrick Picavet THR equation

The harm reduction equation

RELATED ARTICLES EXPOSURE MASTER

Exposure response study on Platform 1